JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stennicke, H. R.
Right arrow Articles by Salvesen, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stennicke, H. R.
Right arrow Articles by Salvesen, G. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 41, Issue of October 10, 1997 pp. 25719-25723
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Biochemical Characteristics of Caspases-3, -6, -7, and -8*

(Received for publication, June 20, 1997, and in revised form, August 4, 1997)

Henning R. Stennicke Dagger and Guy S. Salvesen §

From The Program in Apoptosis and Cell Death, The Burnham Institute, La Jolla, California 92037

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The observation that the nematode cell death effector gene product Ced-3 is homologous to human interleukin-1beta -converting enzyme (caspase-1) has led to the discovery of at least nine other human caspases, many of which are implicated as mediators of apoptosis. Significant interest has been given to aspects of the cell biology and substrate specificity of this family of proteases; however, quantitative descriptions of their biochemical characteristics have lagged behind. We describe the influence of a number of environmental parameters, including pH, ionic strength, detergent, and specific ion concentrations, on the activity and stability of four caspases involved in death receptor-mediated apoptosis. Based on these observations, we recommend the following buffer as optimal for investigation of their characteristics in vitro: 20 mM piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES), 100 mM NaCl, 10 mM dithiothreitol, 1 mM EDTA, 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid (CHAPS), 10% sucrose, pH 7.2. Caspase activity is not affected by concentrations of Ca2+ below 100 mM, but is abolished by Zn2+ in the submicromolar range, a common characteristic of cysteine proteases. Optimal pH values vary from 6.8 for caspase-8 to 7.4 for caspase-3, and activity of all is relatively stable between 0 and 150 mM NaCl. Consequently, changes in the physiologic pH and ionic strength would not significantly alter the activity of the enzymes, inasmuch as all four caspases are optimally active within the range of these parameters found in the cytosol of living and dying human cells.


INTRODUCTION

Apoptotic cell death is a process that enables metazoans to eliminate cells that are damaged, mislocated, or have become superfluous, and is characterized by controlled proteolysis of cellular components resulting from activation of an in-built program (2, 3). The signal for the execution of the cell may come from various stimuli: specific death receptor ligation (4), ionizing radiation (5), anti-neoplastic drugs (6), and growth factor withdrawal (7). However, despite the variety of death signals, the key features of execution appear to be quite similar; the death signal converges upon the activation of a number of proteases, which in turn cleave protein substrates (8, 9), thus giving rise to characteristic apoptotic morphology.

Since the discovery that ced-3, a key effector gene of programmed cell death in Caenorhabditis elegans, exhibited homology with interleukin 1beta -converting enzyme (ICE1 or caspase-1), the involvement of proteolytic enzymes in apoptosis has been an issue of significant interest (10-12). This has resulted in the cloning of several mammalian genes encoding ICE/Ced-3 homologues, known commonly as caspases (13), several of which are important for promotion of the death pathway in mammals (reviewed in Ref. 9). However, with the notable exception of caspase-1 (14-16), little attention has been given to the key biochemical properties of these enzymes, which is important for understanding the effect of the intracellular environment on their activity. For example, changes in pH, redox potential, and Zn2+ concentration all have effects on apoptosis (17-21). In the present article, we present a characterization of some of the basic biochemical properties of four of the caspases. We have chosen to focus on those that play a central role in the apoptotic pathway initiated by ligation of the death receptors Fas and tumor necrosis receptor 1: caspase-3 (Yama/CPP32/apopain), caspase-6 (Mch2), caspase-7 (Lap3/Mch3/CMH1), and caspase-8 (FLICE/MACH) (22-26).


EXPERIMENTAL PROCEDURES

Materials

Active caspases-3, -6, -7, and -8 were expressed in Escherichia coli and isolated as described previously (22, 24, 27). The expression constructs for caspases-3, -6, and -7 contained a His6 tag at the C terminus of the full-length protein, while caspase-8 was constructed to have a His6 tag at the N terminus replacing residues 1-216 of the zymogen. The concentrations of the purified enzymes were determined from the absorbance at 280 nm based on the molar absorption coefficients for the caspases calculated from the Edelhoch relationship (28): caspase-3 (epsilon 280 = 26000 M-1 cm-1), caspase-6 (epsilon 280 = 26000 M-1 cm-1), caspase-7 (epsilon 280 = 24510 M-1 cm-1), and caspase-8 (epsilon 280 = 27390 M-1 cm-1). Carbobenzoxy-Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl coumarin (Z-DEVD-AFC) was purchased from Enzyme System Products. DTT was from Diagnostic Chemicals Limited. Sucrose was from Mallinckrodt. All other chemicals were from Sigma. Z-DEVD-fluoromethyl ketone was the kind gift of Joe Krebbs, IDUN Pharmaceuticals.

Determination of the pH Dependence of the Caspases

The pH dependence of the hydrolysis of the substrate Z-DEVD-AFC were evaluated in the pH range 5.5-10. The enzymatic reaction was carried out at 37 °C in the following buffers: 20 mM MES (pH 5.5-6.5), 20 mM HEPES (pH 6.2-7.3), 20 mM PIPES (pH 6.9-8.1), 20 mM Bicine (pH 7.8-9.0) or 20 mM CHES (pH 8.8-10.0), containing NaCl, DTT (fresh), EDTA, CHAPS, and sucrose at optimized concentrations as described under "Results and Discussion." For reasons discussed later, the optimal buffer used as a basis for further studies was 20 mM PIPES, 100 mM NaCl, 10 mM DTT, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, pH 7.2. The enzyme concentrations used were 1.2 nM (caspase-3), 18 nM (caspase-6), 5 nM (caspase-7), and 80 nM (caspase-8). The initial rates of enzymatic hydrolysis were measured by release of AFC from the substrate Z-DEVD-AFC (0.1 mM) as emission at 505 nm upon excitation at 400 nm using a Perkin-Elmer LS50B fluorimeter equipped with a thermostated plate reader. The pH dependences of the initial rates of hydrolysis for all four caspases were fitted to a bell shape described for two ionizing groups by the equation v = (limit × log(pH - pKa1))/(log(2 × pH - pKa1 -pKa2) + log(pH - pKa1) + 1)) using Grafit 3.01 (29).

Determination of the Zn2+ and Ca2+ Ion Sensitivity of the Caspases

The sensitivity toward Zn2+ and Ca2+ was determined in optimal buffer (without EDTA), containing varying concentrations of ZnCl2 or CaCl2 as described above. A concentration of 20 mM beta -mercaptoethanol was used to replace DTT because it does not chelate zinc to the same extent as DTT. The influence of the concentration of the reductant on the zinc sensitivity was exploited for caspase-3 using varying concentrations of beta -mercaptoethanol. The inhibition of the caspases by ZnCl2 was fitted to an equation describing simple competitive inhibition, v = Vmax/(1 + ((Ks/[S]) × (1 + ([Zn2+]/KZn)))) using Grafit 3.01 (29).

Determination of the Sensitivity of the Caspases to Ionic Strength

The sensitivity toward ionic strength was determined in optimal buffer containing varying concentrations of NaCl as described above.

Determination of the in Vitro Stability of the Caspases

The stability of the four caspases was determined by incubating the enzymes in optimal buffer at 0 °C or 37 °C. At various time points, a sample was withdrawn and the activity was determined as described above.


RESULTS AND DISCUSSION

The Caspases

Heterologous expression of the caspases is required to obtain sufficient amounts of starting material for a rigorous characterization. Although the mechanism is not understood, when expressed in E. coli, these caspases spontaneously undergo what appears to be autoprocessing to yield the appropriate subunits characteristic of the active enzymes (Fig. 1). Processing at interdomain Asp residues was confirmed for all of the recombinant proteases by sequencing of the N termini of the two subunits (see Refs. 22 and 27 for further details). Note that both the large and small subunits migrate as homogeneous bands in SDS-PAGE, with the exception of the large subunit of caspase-6, which, based on N-terminal sequencing, represents alternative cleavages at the C terminus of the large subunit. The N-terminal peptides of caspases-3, -6, and -7 were also removed during processing, as demonstrated to occur during Fas-mediated apoptosis in vivo (22). Caspase-8 could not be expressed as a full-length protein and thus was engineered with a 21-residue linker (24, 27) that replaces the 216-residue N-terminal segment removed during its activation in vivo after Fas ligation (25, 26). Consequently, with the exception of the terminal purification tags, the proteins are essentially identical to the forms identified or expected in vivo in apoptotic cells. On the basis of titration with the active site-directed caspase inhibitor Z-DEVD-fluoromethyl ketone, all proteases were 100% active, based on absorbance at 280 nm, with the exception of caspase-8, which was 50% active.


Fig. 1. SDS-PAGE analysis of the purified recombinant caspases. Approximately 5 µg of each caspase was electrophoresed in a linear 5-15% SDS-PAGE gel (40), followed by staining with Coomassie Blue. The gel demonstrates the presence of the large and small subunits characteristic of the activated enzymes, as well as the purity of the preparations used in this study.
[View Larger Version of this Image (62K GIF file)]

Effects of Sucrose and Detergent

Common to all the caspases is a distinct preference for aspartic acid in the P1 position.2 In the present study, we have used Z-DEVD-AFC as the test substrate even though the four caspases investigated exhibit some degree of P4 preference. Use of this substrate is suitable, inasmuch as we are interested in the properties of the caspases and not in the possible effects that the change of various parameters may have on the protein substrates.

Initially, the requirements for various components were investigated in a buffer based on that used by Thornberry et al. for caspase-1 (11): 20 mM HEPES, 100 mM NaCl, 10 mM DTT, 0.1% CHAPS, 10% sucrose, pH 7.4. Table I demonstrates the effects of removal of some of these component from the assay buffer. All four caspases lose over 40% of their activity upon removal of CHAPS from the buffer, and the effect is more dramatic with caspase-6 than with caspases-3, -7, and -8. Only minor beneficial effects are found with sucrose and NaCl; in the case of caspase-6, there is a significant reduction in activity in the presence of NaCl, which will be discussed in detail below. However, 100 mM NaCl is required in the assay buffer to maintain a consistent ionic strength when varying pH. A relatively high concentration of DTT (10 mM) is required for full activity of the recombinant enzymes. They may be preactivated by DTT and the DTT removed by gel filtration; however, if neither reducing agent nor EDTA is present in the exchange buffer, the activity declines rapidly, presumably due to oxidation of the catalytic cysteine (data not shown). EDTA (1 mM) is incorporated into the assay buffer to avoid inactivation by trace metals.

Table I. Effect of removing various compounds from the assay buffer

The effects shown describe the fractional activity in buffer without components relative to one containing them.

Caspase-3 Caspase-6 Caspase-7 Caspase-8

CHAPS 0.59 0.03 0.39 0.30
Sucrose 0.95 0.82 0.81 0.92
NaCl 0.97 1.69 0.78 0.97

Effects of pH

Only minor differences were observed in the pH profiles of the four caspases. The bell-shaped pH dependence signifies the existence of one active form of the enzyme with the increase in activity most likely due to the de-protonation of the catalytic Cys residue. In this respect, the caspases closely resemble other unrelated cysteine proteases in their activity pH profiles (30). Caspase-3 was found to be active over a broader pH range with an optimum slightly higher than the other three (see Fig. 2). Although we have analyzed the pH dependence of all four enzymes as a simple bell-shaped curve, there is a faster than expected drop-off in activity at low pH, most clearly observed with caspases-3 and -6. This indicates that more than one group is protonating, possibly another group on the enzyme, or the substrate carboxylate(s), inasmuch as the three-dimensional structure of caspases-1 and -3 demonstrates binding of unprotonated side-chains in its specificity pockets (31-33). The pH dependence of these caspases also indicates that they all are fully active within the pH range found in normal as well as apoptotic cells, designated by the shaded background in Fig. 2 (18, 21). It is possible that changes in pH during apoptosis may affect caspase activity indirectly by altering the structure of a particular set of natural substrates. However, this hypothetical event would change only the susceptibility of the substrate, not the activity of the caspases.


Fig. 2. The pH dependence of the four caspases for the hydrolysis of the synthetic peptide substrate Z-DEVD-AFC. The dependence was fitted to a bell shape characterized by the following pKa values: pKa1 = 6.4 and pKa2 = 8.6 for caspase-3, pKa1 = 6.9 and pKa2 = 7.2 for caspase-6, pKa1 = 6.5 and pKa2 = 7.7 for caspase-7, and pKa1 = 6.0 and pKa2 = 7.7 for caspase-8. The shaded area illustrates the pH range found in normal and apoptotic cells, with the latter favoring lower pH (18, 21).
[View Larger Version of this Image (26K GIF file)]

Effects of Ionic Strength

We used NaCl in the range 0-1 M in assay buffer to address the dependence of ionic strength on caspase activity. Differential effects were found depending on the enzyme, with caspases-3 and -8 having fairly flat profiles, whereas caspases-6 and -7 demonstrated maximal activity at 0.03 M and 0.25 M (Fig. 3). Although the activity of caspase-6 declined faster than the others as ionic strength increased, none of the enzymes demonstrated substantial adverse effects on their activity in the physiologic range of ionic strength (34), designated by the shaded background in Fig. 3. The apparent stability to substantial changes in ionic strength indicates that this would not be limiting during commitment to apoptosis.


Fig. 3. NaCl dependence of caspases. Caspases-3 (open circle ), -6 (square ), -7 (black-square), and -8 (bullet ) were incubated under optimal buffer conditions, with the indicated concentration of NaCl, and initial rates of substrate hydrolysis determined. The rates of hydrolysis have been normalized to the rate of hydrolysis in the absence of NaCl. The shaded area illustrates the range of ionic strength normally found in the cytosol (34).
[View Larger Version of this Image (27K GIF file)]

Effects of Zn2+and Ca2+

Several studies have reported that Zn2+ inhibits apoptosis. Originally, this effect was believed to be due to the inhibition of nucleases; however, caspase-6 (17) and, more recently, caspase-3 (20) have been found to be inhibited completely by 2 mM Zn2+. The influence of transition metal ions on the activity of cysteine proteases has been well established for a long time; for instance, members of the papain family are sensitive to Zn2+, mercury, and various organomecurials (35, 36). Because DTT chelates Zn2+, we compared caspases for sensitivity to this ion in the presence of 20 mM beta -mercaptoethanol, which we determined to be the concentration of this reductant required for optimal activity of the recombinant enzymes (data not shown). Due to the inherent tendency of Zn2+ to react with thiols, we can only obtain an apparent binding constant and, under these conditions, all the caspases are inhibited by small amounts of Zn2+, although there are significant differences in the affinity (Fig. 4). Caspase-6 is most readily inhibited by Zn2+, completely inactivated by 0.1 mM, and caspase-3 is the least sensitive, requiring more than 1 mM for complete inactivation. To estimate the real binding affinity, we probed the influence of reductant on the inhibition of caspase-3 by Zn2+. Not surprisingly, there was a significant influence of the concentration of beta -mercaptoethanol on the KZn,app giving rise to values converging on an approximate value of 0.15 µM (Fig. 5). From these results, it is quite evident that Zn2+ is a good inhibitor of the caspases, albeit very dependent on the thiol content, and therefore presumably the redox potential of the cell. The influence of Ca2+ was investigated in a similar manner and was found to have no effect on the activity of any of the caspases at concentrations up to 100 mM (data not shown). Thus, the reported role of Ca2+ in apoptosis (see, for example, Ref. 37) is unlikely to be due to any effect on the caspases.


Fig. 4. Sensitivity of the four caspases to the presence of Zn2+. Caspases were incubated under optimal buffer conditions, with DTT replaced by beta -mercaptoethanol, at the indicated concentration of Zn2+, and initial rates of substrate hydrolysis determined. The apparent binding constants for Zn2+ to the individual caspases (KZn,app) are 8.8 µM for caspase-3, 0.3 µM for caspase-6, 1.7 µM for caspase-7, and 1.9 µM for caspase-8.
[View Larger Version of this Image (23K GIF file)]


Fig. 5. Influence of the concentration of beta -mercaptoethanol on the apparent binding constant for Zn2+ to caspase-3. The influence of beta -mercaptoethanol on KZn,app were investigated using the concentrations 0.25 mM (black-down-triangle ), 0.5 mM (down-triangle), 1 mM (black-triangle), 2 mM (triangle ), 4 mM (black-square), 8 mM (square ), 16 mM (bullet ), and 32 mM (open circle ).
[View Larger Version of this Image (25K GIF file)]

In Vitro Stability

On the basis of the foregoing results, the optimal general caspase buffer was designated as 20 mM PIPES, 100 mM NaCl, 10 mM DTT, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, pH 7.2. The stability of the four caspases was tested by incubating the enzymes at 0 °C or 37 °C in the optimal assay buffer and determining the activity at various times (Fig. 6). None of the caspases showed any decrease in activity at 0 °C over the 150-min period. Caspases-3 and -6 retained full activity for 150 min at 37 °C, whereas caspases-7 and -8 showed an appreciable decrease in activity. To verify that the decrease in activity observed at 37 °C with caspases-7 and -8 was not due to sample variation, the experiment was performed with two different preparations of these enzymes giving rise to almost identical results, reducing the probability that the decrease in activity is associated with sample variations. The reason for the decrease in activity is not clear; however, SDS-PAGE analysis of caspases incubated at 0 °C and 37 °C for 150 min does not reveal any indications of degradation (data not shown). Based on these observations, the most probable explanation is a conformational change, possibly due to slow dissociation of the subunits after dilution into assay buffer, as originally described for caspase-1 (11). This assumption is supported because the decrease in activity observed with caspase-8 appears to approach a level of approximately 60%, and remains there for an extended period of time. Whether such dissociation occurs in a cell under physiologic conditions remains an open question, but it is evident that none of the investigated caspases undergo autolysis that will significantly affect their role in apoptosis. This is in contrast to caspase-1, which has been shown to inactivate spontaneously by autolytic degradation of its small subunit (38).


Fig. 6. In vitro stability of the caspases. The stability of the caspases in optimal buffer at 0 °C (open circle ) and 37 °C (bullet ) were determined by measuring the residual activity as a function of time.
[View Larger Version of this Image (21K GIF file)]

Biologic Perspective

The results demonstrate that all four caspases are optimally active under normal physiologic conditions. We have to activate the recombinant enzymes by adding thiols, presumably because of reversible modification of the catalytic cysteine during expression and purification. In vivo, however, the glutathione balance would favor the reduced form, with the result that, once processed from their single chain zymogens, the caspases would be fully active. We do not rule out the possibility that natural caspase substrates are affected by changes in environmental parameters that would alter their susceptibility to specific proteolysis in vivo. In this context, caspase-1 was shown to exhibit a marked salt dependence due to effects of NaCl on the substrate pro-interleukin-1beta , but not on a synthetic peptidyl substrate (39). However, changes in the pH and ionic strength of the cytosol would not significantly alter the activity of the enzymes themselves, inasmuch as all four caspases are optimally active within the range of these parameters found within cell cytosols, irrespective of their metabolic status.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported by Danish Natural Science Foundation Grant 9600412.
§   To whom correspondence should be addressed: The Burnham Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 619-646-3114; Fax: 619-646-3189; E-mail: gsalvesen{at}ljcrf.edu.
1   The abbreviations used are: ICE, interleukin-1beta -converting enzyme; Z, carbobenzoxy; DTT, dithiothreitol; MES, 2-(N-morpholino)ethanesulfonic acid; CHES, 2-(N-cyclohexylamino)ethanesulfonic acid; PIPES, piperazine-N,N'-bis(2-ethanesulfonic acid); CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid; Bicine, N,N-bis(2-hydroxyethyl)glycine; AFC, 7-amino-4-trifluoromethyl coumarin; PAGE, polyacrylamide gel electrophoresis.
2   Binding site nomenclature is in accordance with the nomenclature of Schechter and Berger (1).

ACKNOWLEDGEMENTS

We thank Yuri Lazebnik for helpful discussion of this manuscript, Qiao Zhou for performing the active site titration of the caspases, and Annamarie Price and Scott Snipas for technical assistance. We thank Joe Krebbs for providing us with Z-DEVD-fluoromethyl ketone.


REFERENCES

  1. Schechter, I., and Berger, A. (1967) Biochem. Biophys. Res. Commun. 27, 157-162 [CrossRef][Medline] [Order article via Infotrieve]
  2. Ellis, H. M., and Horvitz, H. R. (1986) Cell 44, 817-829 [CrossRef][Medline] [Order article via Infotrieve]
  3. Kerr, J. F. R., and Harmon, B. V. (1991) in Apoptosis: The Molecular Basis of Cell Death. (Tomei, L. D., and Cope, F. O., eds), p. 321, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  4. Tewari, M., and Dixit, V. M. (1995) J. Biol. Chem. 270, 3255-3260 [Abstract/Free Full Text]
  5. Datta, R., Kojima, H., Banach, D., Bump, N. J., Talanian, R. V., Alnemri, E. S., Weichselbaum, R. R., Wong, W. W., and Kufe, D. W. (1997) J. Biol. Chem. 272, 1965-1969 [Abstract/Free Full Text]
  6. Fearnhead, H. O., McCurrach, M. E., O'Neill, J., Zhang, K., Lowe, S. W., and Lazebnik, Y. A. (1997) Genes Dev. 11, 1266-1276 [Abstract/Free Full Text]
  7. Deckwerth, T. L., and Johnson, E. M., Jr. (1993) J. Cell Biol. 123, 1207-1222 [Abstract/Free Full Text]
  8. Martin, S. J., and Green, D. R. (1995) Cell 82, 349-352 [CrossRef][Medline] [Order article via Infotrieve]
  9. Chinnaiyan, A. M., and Dixit, V. M. (1996) Curr. Biol. 6, 555-562 [CrossRef][Medline] [Order article via Infotrieve]
  10. Ceretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., van Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A., Huebner, K., and Black, R. A. (1992) Science 256, 97-100 [Abstract/Free Full Text]
  11. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J.-F., Egger, L. A., Gaffney, G. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T.-T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, M. J., and Tocci, M. J. (1992) Nature 356, 768-774 [CrossRef][Medline] [Order article via Infotrieve]
  12. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. M. (1993) Cell 75, 641-652 [CrossRef][Medline] [Order article via Infotrieve]
  13. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G. S., Thornberry, N. A., Wong, W. W., and Yuan, J. (1996) Cell 87, 171 [CrossRef][Medline] [Order article via Infotrieve]
  14. Black, R. A., Kronheim, S. R., Merriam, J. E., March, C. J., and Hopp, T. P. (1989) J. Biol. Chem. 264, 5323-5326 [Abstract/Free Full Text]
  15. Sleath, P. R., Hendrickson, R. C., Kronheim, S. R., March, C. J., and Black, R. A. (1990) J. Biol. Chem. 265, 14526-14528 [Abstract/Free Full Text]
  16. Rano, T. A., Timkey, T., Peterson, E. P., Rotonda, J., Nicholson, D. W., Becker, J. W., Chapman, K. T., and Thornberry, N. A. (1997) Chem. Biol. 4, 149-155 [CrossRef][Medline] [Order article via Infotrieve]
  17. Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8395-8400 [Abstract/Free Full Text]
  18. Gottlieb, R. A., Nordberg, J., Skowronski, E., and Babior, B. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 654-658 [Abstract/Free Full Text]
  19. Ellerby, L. M., Ellerby, H. M., Park, S. M., Holleran, A. L., Murphy, A. N., Fiskum, G., Kane, D. J., Testa, M. P., Kayalar, C., and Bredesen, D. E. (1996) J. Neurochem. 67, 1259-1267 [Medline] [Order article via Infotrieve]
  20. Perry, D. K., Smyth, M. J., Stennicke, H. R., Salvesen, G. S., Duriez, P., Poirier, G. G., and Hannun, Y. A. (1997) J. Biol. Chem. 272, 18530-18533 [Abstract/Free Full Text]
  21. Meisenholder, G. W., Martin, S. J., Green, D. R., Nordberg, J., Babior, B. M., and Gottlieb, R. A. (1996) J. Biol. Chem. 271, 16260-16262 [Abstract/Free Full Text]
  22. Orth, K., O'Rourke, K., Salvesen, G. S., and Dixit, V. M. (1996) J. Biol. Chem. 271, 20977-20980 [Abstract/Free Full Text]
  23. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14486-14491 [Abstract/Free Full Text]
  24. Muzio, M., Salvesen, G. S., and Dixit, V. M. (1997) J. Biol. Chem. 272, 2952-2956 [Abstract/Free Full Text]
  25. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996) Cell 85, 803-815 [CrossRef][Medline] [Order article via Infotrieve]
  26. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996) Cell 85, 817-827 [CrossRef][Medline] [Order article via Infotrieve]
  27. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., and Salvesen, G. S. (1997) J. Biol. Chem. 272, 7797-7800 [Abstract/Free Full Text]
  28. Edelhoch, H. (1967) Biochemistry 6, 1948-1954 [CrossRef][Medline] [Order article via Infotrieve]
  29. Leatherbarrow, R. J. (1993) Grafit, Version 3.01, Erithacus Software Ltd., Staines, United Kingdom
  30. Lewis, E. R., Johnson, F. A., and Shafer, J. A. (1981) Biochemistry 20, 48-51 [CrossRef][Medline] [Order article via Infotrieve]
  31. Wilson, K. P., Black, J.-A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., and Livingston, D. J. (1994) Nature 370, 270-275 [CrossRef][Medline] [Order article via Infotrieve]
  32. Rotonda, J., Nicholson, D. W., Fazil, K. M., Gallant, M., Gareau, Y., Labelle, M., Peterson, E. P., Rasper, D. M., Ruel, R., Vaillancourt, J. P., Thornberry, N. A., and Becker, J. W. (1996) Nat. Struct. Biol. 3, 619-625 [CrossRef][Medline] [Order article via Infotrieve]
  33. Walker, N. P. C., Talanian, R. V., Brady, K. D., Dang, L. C., Bump, N. J., Ferenz, C. R., Franklin, S., Ghayur, T., Hackett, M. C., Hammill, L. D., Herzog, L., Hugunin, M., Houy, W., Mankovich, J. A., McGuiness, L., Orlewicz, E., Paskind, M., Pratt, C. A., Reis, P., Summani, A., Terranova, M., Welch, J. P., Xiong, L., and Müller, A. (1994) Cell 78, 343-352 [CrossRef][Medline] [Order article via Infotrieve]
  34. Godt, R. E., and Maughan, D. W. (1988) Am. J. Physiol. 254, C591-C604 [Abstract/Free Full Text]
  35. Sluyterman, L. A., and Wijdenes, J. (1976) Eur. J. Biochem. 71, 383-391 [Medline] [Order article via Infotrieve]
  36. Bond, J. S. (1989) in Proteolytic Enzymes: A Practical Approach (Beynon, R. J., and Bond, J. S., eds), pp. 232-240, IRL Press, Oxford
  37. Bian, X., Hughes, F. M., Jr., Huang, Y., Cidlowski, J. A., and Putney, J. W., Jr. (1997) Am. J. Physiol. 272, C1241-C1249 [Abstract/Free Full Text]
  38. Talanian, R. V., Dang, L. C., Ferenz, C. R., Hackett, M. C., Mankovich, J. A., Welch, J. P., Wong, W. W., and Brady, K. D. (1996) J. Biol. Chem. 271, 21853-21858 [Abstract/Free Full Text]
  39. Miller, D. (1996) in Therapeutic Modulation of Cytokines (Henderson, B., and Bodmer, M. W., eds), pp. 143-170, Springer Verlag, Berlin
  40. Bury, A. (1981) J. Chromatog. 213, 491-500 [CrossRef]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
G. Klaiman, T. L. Petzke, J. Hammond, and A. C. LeBlanc
Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease
Mol. Cell. Proteomics, August 1, 2008; 7(8): 1541 - 1555.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Masini, L. Giannini, S. Nistri, L. Cinci, R. Mastroianni, W. Xu, S. A. A. Comhair, D. Li, S. Cuzzocrea, G. M. Matuschak, et al.
Ceramide: a Key Signaling Molecule in a Guinea Pig Model of Allergic Asthmatic Response and Airway Inflammation
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 548 - 557.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bosch and V. E. Franklin-Tong
Temporal and spatial activation of caspase-like enzymes induced by self-incompatibility in Papaver pollen
PNAS, November 13, 2007; 104(46): 18327 - 18332.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
L. Lombardi, S. Casani, N. Ceccarelli, L. Galleschi, P. Picciarelli, and R. Lorenzi
Programmed cell death of the nucellus during Sechium edule Sw. seed development is associated with activation of caspase-like proteases
J. Exp. Bot., August 28, 2007; (2007) erm137v1.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Tanel and D. A. Averill-Bates
Inhibition of Acrolein-Induced Apoptosis by the Antioxidant N-Acetylcysteine
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 73 - 83.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. A. Shaman, R. Prisztoka, and W. S. Ward
Topoisomerase IIB and an Extracellular Nuclease Interact to Digest Sperm DNA in an Apoptotic-Like Manner
Biol Reprod, November 1, 2006; 75(5): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
K. K. Raju, S. Gautam, and A. Sharma
Molecules involved in the modulation of rapid cell death in xanthomonas.
J. Bacteriol., August 1, 2006; 188(15): 5408 - 5416.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A Higuchi, S Shimmura, T Takeuchi, M Suematsu, and K Tsubota
Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells
Br. J. Ophthalmol., June 1, 2006; 90(6): 760 - 764.
[Abstract] [Full Text] [PDF]


Home page
CSH ProtocolsHome page
S. Kasibhatla, G. P. Amarante-Mendes, D. Finucane, T. Brunner, E. Bossy-Wetzel, and D. R. Green
Biochemical Analysis of Cell Death Using Colorimetric Quantification of Caspase Activation
CSH Protocols, May 1, 2006; 2006(1): pdb.prot4435 - pdb.prot4435.
[Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. R. Cima, J. M. Dubach, A. M. Wieland, B. M. Walsh, and D. I. Soybel
Intracellular Ca2+ and Zn2+ signals during monochloramine-induced oxidative stress in isolated rat colon crypts
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G250 - G261.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Feeney and A. C. Clark
Reassembly of Active Caspase-3 Is Facilitated by the Propeptide
J. Biol. Chem., December 2, 2005; 280(48): 39772 - 39785.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Gilot, A.-L. Serandour, G. P. Ilyin, D. Lagadic-Gossmann, P. Loyer, A. Corlu, A. Coutant, G. Baffet, M. E. Peter, O. Fardel, et al.
A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes
Carcinogenesis, December 1, 2005; 26(12): 2086 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. V. Bozhkov, M. F. Suarez, L. H. Filonova, G. Daniel, A. A. Zamyatnin Jr., S. Rodriguez-Nieto, B. Zhivotovsky, and A. Smertenko
Cysteine protease mcII-Pa executes programmed cell death during plant embryogenesis
PNAS, October 4, 2005; 102(40): 14463 - 14468.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. B. Blumenthal, A. K. Kiemer, G. Tiegs, S. Seyfried, M. Holtje, B. Brandt, H.-D. Holtje, S. Zahler, and A. M. Vollmar
Metalloporphyrins inactivate caspase-3 and -8
FASEB J, August 1, 2005; 19(10): 1272 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Brooks, P. Ketsawatsomkron, Y. Sui, J. Wang, C.-Y. Wang, F.-S. Yu, and Z. Dong
Acidic pH inhibits ATP depletion-induced tubular cell apoptosis by blocking caspase-9 activation in apoptosome
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F410 - F419.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Bulanova, V. Budagian, Z. Orinska, M. Hein, F. Petersen, L. Thon, D. Adam, and S. Bulfone-Paus
Extracellular ATP Induces Cytokine Expression and Apoptosis through P2X7 Receptor in Murine Mast Cells
J. Immunol., April 1, 2005; 174(7): 3880 - 3890.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. W. Cheung, D.-Y. Jin, M.-t. Ling, Y. C. Wong, Q. Wang, S. W. Tsao, and X. Wang
Mitotic Arrest Deficient 2 Expression Induces Chemosensitization to a DNA-Damaging Agent, Cisplatin, in Nasopharyngeal Carcinoma Cells
Cancer Res., February 15, 2005; 65(4): 1450 - 1458.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Wang, X. Li, L. Wang, Y.-H. Feng, R. Zeng, and G. Gorodeski
Antiapoptotic Effects of Estrogen in Normal and Cancer Human Cervical Epithelial Cells
Endocrinology, December 1, 2004; 145(12): 5568 - 5579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Q. Wang, L. Wang, Y.-H. Feng, X. Li, R. Zeng, and G. I. Gorodeski
P2X7 receptor-mediated apoptosis of human cervical epithelial cells
Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1349 - C1358.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Q. Wei, J. Wang, M.-H. Wang, F. Yu, and Z. Dong
Inhibition of apoptosis by Zn2+ in renal tubular cells following ATP depletion
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F492 - F500.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Ohara, T. Hayashi, Y. Kusunoki, M. Miyauchi, T. Takata, and M. Sugai
Caspase-2 and Caspase-7 Are Involved in Cytolethal Distending Toxin-Induced Apoptosis in Jurkat and MOLT-4 T-Cell Lines
Infect. Immun., February 1, 2004; 72(2): 871 - 879.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Cirman, K. Oresic, G. D. Mazovec, V. Turk, J. C. Reed, R. M. Myers, G. S. Salvesen, and B. Turk
Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal Cathepsins
J. Biol. Chem., January 30, 2004; 279(5): 3578 - 3587.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-H. Wu and P. C. Tai
Cys32 and His105 Are the Critical Residues for the Calcium-dependent Cysteine Proteolytic Activity of CvaB, an ATP-binding Cassette Transporter
J. Biol. Chem., January 9, 2004; 279(2): 901 - 909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. J. Redlak, M. S. Dennis, and T. A. Miller
Apoptosis is a major mechanism of deoxycholate-induced gastric mucosal cell death
Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G870 - G879.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. M. Payne, R. E. Molestina, and A. P. Sinai
Inhibition of caspase activation and a requirement for NF-{kappa}B function in th